vs
Side-by-side financial comparison of ATLANTIC AMERICAN CORP (AAME) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $53.8M, roughly 1.6× ATLANTIC AMERICAN CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 1.1%, a 21.7% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 20.8%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $6.6M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs 7.2%).
The Atlantic Telegraph Company was a company formed on 6 November 1856 to undertake and exploit a commercial telegraph cable across the Atlantic Ocean, the first such telecommunications link.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
AAME vs FDMT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $53.8M | $85.1M |
| Net Profit | $577.0K | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 1.4% | 17.3% |
| Net Margin | 1.1% | 22.8% |
| Revenue YoY | 20.8% | 8508900.0% |
| Net Profit YoY | 128.9% | 139.1% |
| EPS (diluted) | $0.02 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $85.1M | ||
| Q3 25 | $53.8M | $90.0K | ||
| Q2 25 | $55.3M | $15.0K | ||
| Q1 25 | $50.1M | $14.0K | ||
| Q4 24 | $49.0M | $1.0K | ||
| Q3 24 | $44.5M | $3.0K | ||
| Q2 24 | $47.7M | $5.0K | ||
| Q1 24 | $47.0M | $28.0K |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $577.0K | $-56.9M | ||
| Q2 25 | $3.3M | $-54.7M | ||
| Q1 25 | $802.0K | $-48.0M | ||
| Q4 24 | $412.0K | — | ||
| Q3 24 | $-2.0M | $-43.8M | ||
| Q2 24 | $-684.0K | $-35.0M | ||
| Q1 24 | $-2.0M | $-32.4M |
| Q4 25 | — | 17.3% | ||
| Q3 25 | 1.4% | -67983.3% | ||
| Q2 25 | 7.6% | -396373.3% | ||
| Q1 25 | 2.1% | -383007.1% | ||
| Q4 24 | 1.1% | — | ||
| Q3 24 | -5.5% | -1704400.0% | ||
| Q2 24 | -1.8% | -849120.0% | ||
| Q1 24 | -5.3% | -136200.0% |
| Q4 25 | — | 22.8% | ||
| Q3 25 | 1.1% | -63195.6% | ||
| Q2 25 | 6.0% | -364386.7% | ||
| Q1 25 | 1.6% | -342657.1% | ||
| Q4 24 | 0.8% | — | ||
| Q3 24 | -4.5% | -1461433.3% | ||
| Q2 24 | -1.4% | -699060.0% | ||
| Q1 24 | -4.3% | -115717.9% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | $0.02 | $-1.01 | ||
| Q2 25 | $0.15 | $-0.98 | ||
| Q1 25 | $0.03 | $-0.86 | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.10 | $-0.79 | ||
| Q2 24 | $-0.04 | $-0.63 | ||
| Q1 24 | $-0.10 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.4M | $402.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $109.5M | $505.7M |
| Total Assets | $430.9M | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $402.7M | ||
| Q3 25 | $34.4M | $305.1M | ||
| Q2 25 | $46.4M | $293.2M | ||
| Q1 25 | $35.9M | $321.4M | ||
| Q4 24 | $35.6M | $424.9M | ||
| Q3 24 | $23.0M | $501.9M | ||
| Q2 24 | $21.2M | $541.9M | ||
| Q1 24 | $21.2M | $525.9M |
| Q4 25 | — | $505.7M | ||
| Q3 25 | $109.5M | $369.0M | ||
| Q2 25 | $106.2M | $420.9M | ||
| Q1 25 | $102.4M | $469.7M | ||
| Q4 24 | $99.6M | $510.6M | ||
| Q3 24 | $105.8M | $552.9M | ||
| Q2 24 | $100.7M | $588.3M | ||
| Q1 24 | $102.8M | $600.6M |
| Q4 25 | — | $566.7M | ||
| Q3 25 | $430.9M | $424.0M | ||
| Q2 25 | $429.3M | $473.6M | ||
| Q1 25 | $388.4M | $515.7M | ||
| Q4 24 | $393.4M | $560.4M | ||
| Q3 24 | $387.0M | $604.0M | ||
| Q2 24 | $386.0M | $620.1M | ||
| Q1 24 | $365.8M | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.6M | $28.6M |
| Free Cash FlowOCF − Capex | $6.6M | $28.5M |
| FCF MarginFCF / Revenue | 12.3% | 33.5% |
| Capex IntensityCapex / Revenue | 0.1% | 0.1% |
| Cash ConversionOCF / Net Profit | 11.51× | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $19.3M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $28.6M | ||
| Q3 25 | $6.6M | $-46.5M | ||
| Q2 25 | $9.3M | $-43.4M | ||
| Q1 25 | $-722.0K | $-47.8M | ||
| Q4 24 | $4.8M | $-134.6M | ||
| Q3 24 | $90.0K | $-29.4M | ||
| Q2 24 | $416.0K | $-30.2M | ||
| Q1 24 | $-5.3M | $-29.1M |
| Q4 25 | — | $28.5M | ||
| Q3 25 | $6.6M | $-46.6M | ||
| Q2 25 | $9.1M | $-43.4M | ||
| Q1 25 | $-986.0K | $-48.4M | ||
| Q4 24 | $4.6M | $-138.4M | ||
| Q3 24 | $58.0K | $-31.2M | ||
| Q2 24 | $361.0K | $-30.6M | ||
| Q1 24 | $-5.4M | $-29.8M |
| Q4 25 | — | 33.5% | ||
| Q3 25 | 12.3% | -51765.6% | ||
| Q2 25 | 16.5% | -289620.0% | ||
| Q1 25 | -2.0% | -345635.7% | ||
| Q4 24 | 9.3% | -13837100.0% | ||
| Q3 24 | 0.1% | -1038966.7% | ||
| Q2 24 | 0.8% | -611840.0% | ||
| Q1 24 | -11.4% | -106421.4% |
| Q4 25 | — | 0.1% | ||
| Q3 25 | 0.1% | 101.1% | ||
| Q2 25 | 0.3% | 440.0% | ||
| Q1 25 | 0.5% | 4507.1% | ||
| Q4 24 | 0.5% | 378600.0% | ||
| Q3 24 | 0.1% | 59266.7% | ||
| Q2 24 | 0.1% | 6980.0% | ||
| Q1 24 | 0.1% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | 11.51× | — | ||
| Q2 25 | 2.80× | — | ||
| Q1 25 | -0.90× | — | ||
| Q4 24 | 11.65× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAME
| Bankers Fidelity | $30.0M | 56% |
| American Southern | $23.7M | 44% |
FDMT
Segment breakdown not available.
